Published in J Biol Chem on December 19, 2000
Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol (2009) 4.58
Distinct cellular functions of MK2. Mol Cell Biol (2002) 2.12
The alpha(2) integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am J Pathol (2002) 2.09
Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer Res (2009) 1.74
Integrin alpha 2 beta 1 promotes activation of protein phosphatase 2A and dephosphorylation of Akt and glycogen synthase kinase 3 beta. Mol Cell Biol (2002) 1.67
Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin. J Cell Biol (2004) 1.61
The role of cellular adaptation to mechanical forces in atherosclerosis. Arterioscler Thromb Vasc Biol (2008) 1.28
Molecular mechanisms of collagen isotype-specific modulation of smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol (2008) 1.15
p38 MAPK-dependent shaping of the keratin cytoskeleton in cultured cells. J Cell Biol (2007) 1.06
IκB kinase β regulates epithelium migration during corneal wound healing. PLoS One (2011) 1.00
Lung cancer cells that survive ionizing radiation show increased integrin α2β1- and EGFR-dependent invasiveness. PLoS One (2013) 0.97
Functional analysis of the cytoplasmic domain of the integrin {alpha}1 subunit in endothelial cells. Blood (2008) 0.97
Cross-talk between integrins alpha1beta1 and alpha2beta1 in renal epithelial cells. Exp Cell Res (2008) 0.96
Activated Src increases adhesion, survival and alpha2-integrin expression in human breast cancer cells. Biochem J (2004) 0.96
Development of transgenic cloned pig models of skin inflammation by DNA transposon-directed ectopic expression of human β1 and α2 integrin. PLoS One (2012) 0.94
The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imaging. BMC Cancer (2010) 0.91
Galectin-3- and phospho-caveolin-1-dependent outside-in integrin signaling mediates the EGF motogenic response in mammary cancer cells. Mol Biol Cell (2013) 0.88
Biomechanical force in blood development: extrinsic physical cues drive pro-hematopoietic signaling. Differentiation (2013) 0.83
Why cellular stress suppresses adipogenesis in skeletal tissue, but is ineffective in adipose tissue: control of mesenchymal cell differentiation via integrin binding sites in extracellular matrices. Matrix Biol (2013) 0.82
Identification of inhibitors of α2β1 integrin, members of C-lectin type proteins, in Echis sochureki venom. Toxicol Appl Pharmacol (2013) 0.77
Mitigation of oxygen-induced retinopathy in α2β1 integrin-deficient mice. Invest Ophthalmol Vis Sci (2014) 0.76
Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells. Biochem J (2017) 0.75
Involvement of the Integrin α1β1 in the Progression of Colorectal Cancer. Cancers (Basel) (2017) 0.75
Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med (1990) 3.35
The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg++-dependent adhesion of platelets to collagen. J Cell Biol (1989) 2.44
Alteration of collagen-dependent adhesion, motility, and morphogenesis by the expression of antisense alpha 2 integrin mRNA in mammary cells. J Cell Sci (1995) 2.39
Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell (1986) 2.38
Altered integrin expression and the malignant phenotype: the contribution of multiple integrated integrin receptors. J Mammary Gland Biol Neoplasia (1998) 2.30
A monoclonal antibody against human thrombospondin inhibits platelet aggregation. Proc Natl Acad Sci U S A (1985) 2.04
Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol Biol Cell (1996) 1.94
Isolation and characterization of a heparin-binding domain from the amino terminus of platelet thrombospondin. J Biol Chem (1984) 1.94
The platelet glycoprotein thrombospondin binds specifically to sulfated glycolipids. J Biol Chem (1985) 1.90
Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am J Pathol (1990) 1.82
The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg (1995) 1.80
Re-expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci U S A (1995) 1.80
Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen. J Biol Chem (1991) 1.79
Mapping of epitopes for monoclonal antibodies against human platelet thrombospondin with electron microscopy and high sensitivity amino acid sequencing. J Cell Biol (1985) 1.62
Acute lymphoblastic leukemia with an unusual t(8;14)(q11.2;q32): a Pediatric Oncology Group Study. Leukemia (2000) 1.60
Bone marrow staging in patients with non-Hodgkin's lymphoma: is flow cytometry a useful test? Cancer (1998) 1.49
Widespread histologic distribution of the alpha 2 beta 1 integrin cell-surface collagen receptor. Am J Pathol (1990) 1.48
Pro-collagenase-1 (matrix metalloproteinase-1) binds the alpha(2)beta(1) integrin upon release from keratinocytes migrating on type I collagen. J Biol Chem (2001) 1.46
Decorin binds near the C terminus of type I collagen. J Biol Chem (2000) 1.40
The spatial and temporal expression of the alpha 2 beta 1 integrin and its ligands, collagen I, collagen IV, and laminin, suggest important roles in mouse mammary morphogenesis. Differentiation (1995) 1.38
Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients. Int J Cancer (1991) 1.36
Localization of the hemagglutinating activity of platelet thrombospondin to a 140 000-dalton thermolytic fragment. Biochemistry (1984) 1.33
Competition for related but nonidentical binding sites on the glycoprotein IIb-IIIa complex by peptides derived from platelet adhesive proteins. Cell (1987) 1.30
Activated platelets express IL-1 activity. J Immunol (1989) 1.24
Effects of anti-thrombospondin monoclonal antibodies on the agglutination of erythrocytes and fixed, activated platelets by purified thrombospondin. Biochemistry (1985) 1.21
Isolation of the fibrinogen-binding region of platelet thrombospondin. Biochem Biophys Res Commun (1984) 1.17
Collagen receptor control of epithelial morphogenesis and cell cycle progression. Am J Pathol (1999) 1.16
Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg (1994) 1.16
The alpha 2 beta 1 integrin cell surface collagen receptor binds to the alpha 1 (I)-CB3 peptide of collagen. J Biol Chem (1990) 1.16
Altered integrin expression in adenocarcinoma of the breast. Analysis by in situ hybridization. Am J Pathol (1993) 1.15
The alpha 2 beta 1 integrin: a collagen receptor on platelets and other cells. Thromb Haemost (1995) 1.14
Ligand recognition by the I domain-containing integrins. Cell Mol Life Sci (1998) 1.14
Induced cell surface expression of functional alpha 2 beta 1 integrin during megakaryocytic differentiation of K562 leukemic cells. Exp Cell Res (1992) 1.14
Loss of MDCK cell alpha 2 beta 1 integrin expression results in reduced cyst formation, failure of hepatocyte growth factor/scatter factor-induced branching morphogenesis, and increased apoptosis. J Cell Sci (1995) 1.10
A three-dimensional collagen lattice activates NF-kappaB in human fibroblasts: role in integrin alpha2 gene expression and tissue remodeling. J Cell Biol (1998) 1.09
ERK and p38 MAP kinase pathways are mediators of intestinal epithelial wound-induced signal transduction. Biochem Biophys Res Commun (1997) 1.09
NAG-2, a novel transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins. J Biol Chem (1997) 1.09
Analysis of collagen receptors. Methods Enzymol (1994) 1.09
Inhibition of platelet aggregation by a monoclonal antibody against human fibronectin. Proc Natl Acad Sci U S A (1985) 1.06
Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. J Thorac Cardiovasc Surg (1994) 1.06
Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas. Am J Clin Pathol (2001) 1.02
Complex patterns of expression suggest extensive roles for the alpha 2 beta 1 integrin in murine development. Dev Dyn (1994) 1.02
The human alpha 2 integrin gene promoter. Identification of positive and negative regulatory elements important for cell-type and developmentally restricted gene expression. J Biol Chem (1994) 1.02
Adsorption of von Willebrand factor by fibrillar collagen--implications concerning the adhesion of platelets to collagen. Coll Relat Res (1982) 1.01
Specific residues within the alpha 2 integrin subunit cytoplasmic domain regulate migration and cell cycle progression via distinct MAPK pathways. J Biol Chem (2001) 0.99
Fibronectin and the multiple interaction model for platelet-collagen adhesion. Proc Natl Acad Sci U S A (1979) 0.98
Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells. J Clin Invest (1991) 0.97
More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT. Thromb Haemost (1996) 0.97
Isolation and characterization of thrombospondin. Methods Enzymol (1987) 0.96
Determinants of ligand binding specificity of the alpha(1)beta(1) and alpha(2)beta(1) integrins. J Biol Chem (1999) 0.95
Collagen-mediated platelet aggregation. Evidence for multivalent interactions of intermediate specificity between collagen and platelets. J Clin Invest (1977) 0.94
Downstream events in mammary gland morphogenesis mediated by reexpression of the alpha2beta1 integrin: the role of the alpha6 and beta4 integrin subunits. Cancer Res (1998) 0.94
Adsorption of von Willebrand factor/factor VIII by the genetically distinct interstitial collagens. Thromb Res (1981) 0.93
Inhibition of platelet aggregation by fibronectin. Biochem Biophys Res Commun (1983) 0.93
Collagen-induced release of interleukin 1 from human blood mononuclear cells. Potentiation by fibronectin binding to the alpha 5 beta 1 integrin. J Clin Invest (1992) 0.92
PDGF induction of alpha 2 integrin gene expression is mediated by protein kinase C-zeta. J Cell Biol (1996) 0.91
Juvenile chronic myelogenous leukemia. Am J Clin Pathol (1996) 0.91
Mammary epithelial cell-cycle progression via the alpha(2)beta(1) integrin: unique and synergistic roles of the alpha(2) cytoplasmic domain. Am J Pathol (2001) 0.91
Antiphospholipid antibodies and thrombotic predisposition: underlying pathogenetic mechanisms. Blood (1994) 0.90
Structural analysis of the alpha(2) integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction. J Biol Chem (2001) 0.90
Characterization of the platelet agglutinating activity of thrombospondin. Biochemistry (1985) 0.90
Collagen receptor integrins: rising to the challenge. Curr Drug Targets (2008) 0.90
Differential expression of integrin alpha subunits supports distinct roles during lung branching morphogenesis. Dev Dyn (1996) 0.89
Lack of expression of surface immunoglobulin light chains in B-cell non-Hodgkin lymphomas. Am J Clin Pathol (2000) 0.89
Contributions of the I and EF hand domains to the divalent cation-dependent collagen binding activity of the alpha2beta1 integrin. J Biol Chem (1997) 0.89
Transcriptional regulation of alpha IIb integrin gene expression during megakaryocytic differentiation of K562 cells. Role of a silencer element. J Biol Chem (1994) 0.87
Collagen-mediated platelet aggregation: the role of multiple interactions between the platelet surface and collagen. Thromb Haemost (1980) 0.86
Differential regulation of the alpha 2 beta 1 and alpha IIb beta 3 integrin genes during megakaryocytic differentiation of pluripotential K562 cells. J Biol Chem (1992) 0.86
Immunophenotypic analysis of hematologic malignancy by laser scanning cytometry. Am J Clin Pathol (1996) 0.85
Megakaryoblastic leukemia presenting as a temporal bone granulocytic sarcoma. Case report. J Neurosurg (1993) 0.85
The ups and downs of alpha 2 beta 1-integrin expression: contributions to epithelial cell differentiation and the malignant phenotype. Curr Top Microbiol Immunol (1998) 0.83
Evaluation of complete blood count results from a new, on-site hemocytometer compared with a laboratory-based hemocytometer. Crit Care Med (1996) 0.82
Integrins and the kidney: biology and pathobiology. Curr Opin Nephrol Hypertens (1999) 0.82
Acute promyelocytic leukemia with additional chromosomal abnormalities and absence of Auer rods. Am J Clin Pathol (1999) 0.81
Immunolocalization of alpha-integrin subunits and extracellular matrix components during human colonic organogenesis. Gastroenterology (1996) 0.80
Preferential binding of high molecular weight forms of von Willebrand factor to fibrillar collagen. Biochim Biophys Acta (1983) 0.80
Interactions of exercise, coagulation, platelets, and fibrinolysis--a brief review. Med Sci Sports Exerc (1988) 0.80
Monitoring activity of fibrinolytic agents. A therapeutic challenge. Am J Med (1984) 0.79
Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements. J Thorac Cardiovasc Surg (1997) 0.79
Recurrent neuroendocrine (Merkel cell) carcinoma of the skin presenting as marrow failure in a man with systemic lupus erythematosus. Med Pediatr Oncol (1993) 0.79
Relative importance of thrombin compared with plasmin-mediated platelet activation in response to plasminogen activation with streptokinase. Circulation (1991) 0.78
Binding of the alpha 2 integrin I domain to extracellular matrix ligands: structural and mechanistic differences between collagen and laminin binding. Cell Adhes Commun (1998) 0.78
Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients. Anesthesiology (1996) 0.77
In vitro reversal of heparin effect with heparinase: evaluation with whole blood prothrombin time and activated partial thromboplastin time in cardiac surgical patients. Anesth Analg (1994) 0.77
Platelet-collagen adhesion. Methods Enzymol (1982) 0.77
Platelet-collagen adhesion-membrane fluidity and the development of high affinity adhesion through multiple interacting sites. Coll Relat Res (1981) 0.77
Differential effects of concanavalin A and succinyl concanavalin A on the macromolecular events of platelet activation. Biochim Biophys Acta (1983) 0.77
Role of the alpha1 and alpha2 integrin cytoplasmic domains in cell morphology, motility and responsiveness to stimulation by the protein kinase C pathway. Cell Adhes Commun (2000) 0.77
Thrombin enhanced adhesion of platelets to von Willebrand factor substrates. Thromb Res (1986) 0.77